Evidence map›Paper›PMID 27976409›Full record

ReviewBiopharmaceutics & drug disposition2017

Oral drug absorption in pediatrics: the intestinal wall, its developmental changes and current tools for predictions.

Jean-Marie Nicolas, François Bouzom, Chanteux Hugues, Anna-Lena Ungell

Open access · bronzeAbstract readReview
In one paragraph

Review in Biopharmaceutics & drug disposition, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
17.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 94 citations in OpenAlex.

  1. Trial
  2. Optimizing Pediatric Drug Therapy: Pediatric Pharmacokinetics and Administration Routes.The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG · 2026
    Article
  3. Review
  4. Article
  5. If a Child Vomits After an Oral Medication-Should We Re-Dose or Not?Acta paediatrica (Oslo, Norway : 1992) · 2025
    Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Self-emulsifying micelles as a drug nanocarrier system for itraconazole oral bioavailability enhancement;Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2023
    Article
  14. Review
  15. Review
  16. Review
  17. Review
  18. Recent advances in the ontogeny of drug disposition.British journal of clinical pharmacology · 2022
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Jean-Marie NicolasNon-Clinical Development Department, UCB Biopharma sprl, Braine-l'Alleud, Belgium.
François BouzomNon-Clinical Development Department, UCB Biopharma sprl, Braine-l'Alleud, Belgium.
Chanteux HuguesNon-Clinical Development Department, UCB Biopharma sprl, Braine-l'Alleud, Belgium.
Anna-Lena UngellNon-Clinical Development Department, UCB Biopharma sprl, Braine-l'Alleud, Belgium.
UCB Pharma (Belgium) · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The dissolution, intestinal absorption and presystemic metabolism of a drug depend on its physicochemical characteristics but also on numerous physiological (e.g. gastrointestinal pH, volume, transit time, morphology) and biochemical factors (e.g. luminal enzymes and flora, intestinal wall enzymes and transporters). Over the past decade, evidence has accumulated indicating that these factors may differ in children and adults resulting in age-related changes in drug exposure and drug response. Thus, drug dosage may require adjustment for the pediatric population to ensure the desired therapeutic outcome and to avoid side-effects. Although tremendous progress has been made in understanding the effects of age on intestinal physiology and function, significant knowledge gaps remain. Studying and predicting pharmacokinetics in pediatric patients remains challenging due to ethical concerns associated with clinical trials in this vulnerable population, and because of the paucity of predictive in vitro and in vivo animal assays. This review details the current knowledge related to developmental changes determining intestinal drug absorption and pre-systemic metabolism. Supporting experimental approaches as well as physiologically based pharmacokinetic modeling are also discussed together with their limitations and challenges. Copyright © 2016 John Wiley & Sons, Ltd.

Indexed as

Models, BiologicalPharmacokineticsAdministration, OralAgingHumansIntestinal AbsorptionIntestinal MucosaIntestinesPediatricsintestinal absorptionontogenypediatricsphysiologically based pharmacokinetic modeling

Identifiers

PMID27976409
PMCPMC5516238
OpenAlexW2567300897

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.